Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Avantor (AVTR)

Avantor Appoints Gregory Lucier to Board of Directors Effective October 3, 2025

Neutral Impact 2 of 5 leadership Written later

Avantor's board elected Gregory Lucier, Executive Chairman and CEO of Corza Medical, as a director effective October 3, 2025, with his term running until the 2026 Annual Meeting of Stockholders. The filing describes this as a board addition with standard non-employee director compensation, and it reports no financial results.

Key points

  • Gregory Lucier elected to the board on October 1, 2025, effective October 3, 2025
  • Annual cash retainer of $95,000, prorated for 2025, plus restricted stock units valued at $210,000 at grant
  • Restricted stock units vest in full one year from grant date, subject to continued board service
  • Board determined Lucier meets New York Stock Exchange independence standards

The filing

CompanyAvantor (AVTR)
Form8-K, current report
Filed with the SECOct 3, 2025, 8:35 AM ET
Accession number0001628280-25-043910

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.